CHYM vs SRAD
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 02, 2026
CHYM
SRAD
Investment Advisor Scores
SRAD
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CHYM | SRAD | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 34.7222 | 36.3636 | CHYM |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 24.8% | 11.3% | CHYM |
| Earnings Growth | -33.8% | -39.9% | CHYM |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 49.3/100 | 55.0/100 | SRAD |
| Profit Margin | -41.9% | 5.3% | SRAD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CHYM
MarkupPrice above SMA50, rising 50-day trend (3.2% over 20 days), RSI 65
SRAD
NeutralMixed signals - no dominant trend phase, RSI 46
Fundamentals Snapshot
| Metric | CHYM | SRAD |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 30.6 | 21.1 |
| Trailing P/E | — | 58.8 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.1% |
| Gross Margin | 0.9% | 0.3% |
| Operating Margin | 0.2% | 0.1% |
| EPS | -4.18 | 0.25 |
| Dividend Yield | — | — |